Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Huntington disease: new insights into molecular pathogenesis and therapeutic opportunities
Sarah J. Tabrizi, Michael Flower, Christopher A. Ross, et al.
Nature Reviews Neurology (2020) Vol. 16, Iss. 10, pp. 529-546
Open Access | Times Cited: 386

Showing 1-25 of 386 citing articles:

Targeted protein degradation: mechanisms, strategies and application
Lin Zhao, Jia Zhao, Kunhong Zhong, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 405
Protein kinase CK2: a potential therapeutic target for diverse human diseases
Christian Borgo, Claudio D’Amore, Stefania Sarno, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 244
Potential disease-modifying therapies for Huntington's disease: lessons learned and future opportunities
Sarah J. Tabrizi, Carlos Estevez‐Fraga, Willeke M. C. van Roon‐Mom, et al.
The Lancet Neurology (2022) Vol. 21, Iss. 7, pp. 645-658
Open Access | Times Cited: 205
Current and Possible Future Therapeutic Options for Huntington’s Disease
Mackenzie Wendy Ferguson, Connor J. Kennedy, Thulani H. Palpagama, et al.
Journal of Central Nervous System Disease (2022) Vol. 14
Open Access | Times Cited: 80
Alternative splicing in neurodegenerative disease and the promise of RNA therapies
David Nikom, Sika Zheng
Nature reviews. Neuroscience (2023) Vol. 24, Iss. 8, pp. 457-473
Closed Access | Times Cited: 77
Targeted gene silencing in the nervous system with CRISPR-Cas13
Jackson E. Powell, Colin K.W. Lim, Ramya Krishnan, et al.
Science Advances (2022) Vol. 8, Iss. 3
Open Access | Times Cited: 75
RhoA Signaling in Neurodegenerative Diseases
Sissel Ida Schmidt, Morten Blaabjerg, Kristine Freude, et al.
Cells (2022) Vol. 11, Iss. 9, pp. 1520-1520
Open Access | Times Cited: 74
Mitochondrial dysfunction in neurodegenerative disorders
Madelyn Klemmensen, Seth H. Borrowman, Colin Pearce, et al.
Neurotherapeutics (2023) Vol. 21, Iss. 1, pp. e00292-e00292
Open Access | Times Cited: 69
The foundation and architecture of precision medicine in neurology and psychiatry
Harald Hampel, Peng Gao, Jeffrey L. Cummings, et al.
Trends in Neurosciences (2023) Vol. 46, Iss. 3, pp. 176-198
Open Access | Times Cited: 67
The mechanism of ferroptosis and its related diseases
Shijian Feng, Dan Tang, Yichang Wang, et al.
Molecular Biomedicine (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 59
Mendelian inheritance revisited: dominance and recessiveness in medical genetics
Johannes Zschocke, Peter H. Byers, Andrew O.M. Wilkie
Nature Reviews Genetics (2023) Vol. 24, Iss. 7, pp. 442-463
Closed Access | Times Cited: 52
Misfolded protein oligomers: mechanisms of formation, cytotoxic effects, and pharmacological approaches against protein misfolding diseases
Dillon J. Rinauro, Fabrizio Chiti, Michele Vendruscolo, et al.
Molecular Neurodegeneration (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 42
Ferroptosis regulation through Nrf2 and implications for neurodegenerative diseases
Yao Xiang, Xiaohua Song, Dingxin Long
Archives of Toxicology (2024) Vol. 98, Iss. 3, pp. 579-615
Open Access | Times Cited: 25
Stem cell therapies for neurological disorders: current progress, challenges, and future perspectives
Ramyar Rahimi Darehbagh, Seyedeh Asrin Seyedoshohadaei, Rojin Ramezani, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 20
Associations Between Diabetes Mellitus and Neurodegenerative Diseases
Leszek Szablewski
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 542-542
Open Access | Times Cited: 2
O-GlcNAcylation in health and neurodegenerative diseases
Byeong Eun Lee, Pann‐Ghill Suh, Jae‐Ick Kim
Experimental & Molecular Medicine (2021) Vol. 53, Iss. 11, pp. 1674-1682
Open Access | Times Cited: 89
DNA Mismatch Repair and its Role in Huntington’s Disease
Ravi R. Iyer, Anna Pluciennik
Journal of Huntington s Disease (2021) Vol. 10, Iss. 1, pp. 75-94
Open Access | Times Cited: 85
Human Sirtuin Regulators: The “Success” Stories
Alyson M. Curry, Dawanna S. White, Dickson Donu, et al.
Frontiers in Physiology (2021) Vol. 12
Open Access | Times Cited: 71
An RNA-targeting CRISPR–Cas13d system alleviates disease-related phenotypes in Huntington’s disease models
Kathryn H. Morelli, Qian Wu, Maya L. Gosztyla, et al.
Nature Neuroscience (2022) Vol. 26, Iss. 1, pp. 27-38
Open Access | Times Cited: 67
Propensity for somatic expansion increases over the course of life in Huntington disease
Radhia Kacher, François‐Xavier Lejeune, Sandrine Noël, et al.
eLife (2021) Vol. 10
Open Access | Times Cited: 62
Protein interaction networks in neurodegenerative diseases: From physiological function to aggregation
Gaetano Calabrese, Cristen Molzahn, Thibault Mayor
Journal of Biological Chemistry (2022) Vol. 298, Iss. 7, pp. 102062-102062
Open Access | Times Cited: 61
TGF-β as a Key Modulator of Astrocyte Reactivity: Disease Relevance and Therapeutic Implications
Jian Luo
Biomedicines (2022) Vol. 10, Iss. 5, pp. 1206-1206
Open Access | Times Cited: 60
Therapeutic reversal of Huntington’s disease by in vivo self-assembled siRNAs
Li Zhang, Tengteng Wu, Yangyang Shan, et al.
Brain (2021) Vol. 144, Iss. 11, pp. 3421-3435
Open Access | Times Cited: 59
Neuroinflammation in Huntington’s Disease: A Starring Role for Astrocyte and Microglia
Julieta Saba, Federico López Couselo, Julieta Bruno, et al.
Current Neuropharmacology (2021) Vol. 20, Iss. 6, pp. 1116-1143
Open Access | Times Cited: 58
MicroRNA Alteration, Application as Biomarkers, and Therapeutic Approaches in Neurodegenerative Diseases
T. P. Nhung Nguyen, Mandeep Kumar, Ernesto Fedele, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 4718-4718
Open Access | Times Cited: 51
Page 1 - Next Page

Scroll to top